Skip to main content

Biotech blind spot: How Canada’s big investors missed the boom happening right now

Cheryl V. Reicin commented in an article in The Globe and Mail exploring how the US funds and individual investors are cashing in on the success of the Canadian biotech industry and why Canadian funds have been slow to invest in this sector. “The real action is just starting,” Cheryl commented.


The Globe and Mail